Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Versus Placebo in Piriformis Muscle Syndrome
NCT07624045Phase 2Not yet recruiting
- Sponsor
- CHU Nîmes
- Start
- Jan 2027
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Piriformis syndrome, sponsored by CHU Nîmes. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Piriformis syndrome
Beyond the preview
Go deeper on NCT07624045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07624045.